GlassScriptPhysician profile
Roger Shiffman
NPI 1033156682
$2,202.70
in general payments reported to CMS, 2019-2025
19 companies · $147 in 2025
The $147 reported for 2025 was less than what a typical Hematology & Oncology provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $576 · 2020: $44.54 · 2021: $440 · 2022: $387 · 2023: $140 · 2024: $468 · 2025: $147.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $755.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $755.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $780.45 | 2021-2025 | Botox |
| Allergan, INC. | $470.97 | 2019-2022 | |
| Merz North America, INC. | $236.36 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $229.07 | 2019-2022 | |
| Daiichi Sankyo INC. | $148.54 | 2021 | |
| Janssen Biotech, INC. | $47.01 | 2020-2021 | |
| Rigel Pharmaceuticals, INC. | $46.74 | 2019-2022 | |
| Lilly USA, LLC | $42.15 | 2019-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $24.79 | 2019 | |
| Tesaro, INC. | $24.20 | 2019 | |
| Incyte Corporation | $23.57 | 2022 | |
| G1 Therapeutics, INC. | $23.53 | 2022 | |
| Emd Serono, INC. | $22.41 | 2022 | |
| Seagen INC. | $21.73 | 2019 | |
| Glaxosmithkline, LLC. | $19.86 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Verastem, INC. | $14.92 | 2019 | |
| Genentech USA, INC. | $14.04 | 2021 | |
| Myriad Genetic Laboratories, INC. | $12.36 | 2022 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roger Shiffman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.